Stay updated on STORM Clinical Trial - Selinexor in Refractory Myeloma
Sign up to get notified when there's something new on the STORM Clinical Trial - Selinexor in Refractory Myeloma page.

Latest updates to the STORM Clinical Trial - Selinexor in Refractory Myeloma page
- CheckyesterdayChange DetectedThe study history now includes the recruitment status note 'No longer looking for participants' and a new revision tag v3.6.0, replacing the previous v3.5.5 entry.SummaryDifference0.2%

- Check8 days agoChange DetectedA new revision, v3.5.5, was added to the page history and the previous revision, v3.5.4, was removed, indicating a behind-the-scenes update to the page.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedA new revision entry v3.5.4 was added to the page history. The previous revision v3.5.3 was removed.SummaryDifference0.1%

- Check50 days agoChange DetectedThe page’s interface revision/version has been updated from **v3.5.2** to **v3.5.3**. No study record content or clinical information appears to change with this revision marker.SummaryDifference0.1%

- Check58 days agoChange DetectedAdded a new revision entry v3.5.2 to the record history and removed the v3.5.0 entry.SummaryDifference0.1%

- Check86 days agoChange DetectedA new site revision entry appears: v3.5.0, replacing the previous v3.4.3.SummaryDifference0.1%

Stay in the know with updates to STORM Clinical Trial - Selinexor in Refractory Myeloma
Enter your email address, and we'll notify you when there's something new on the STORM Clinical Trial - Selinexor in Refractory Myeloma page.